Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

782
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
782
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Brain protein burden is related to intravoxel incoherent motion: PET-MR imaging study.

Frontiers in neuroscience·2026
Same author

Predicting Autopsy-Confirmed Neuropathology across Clinical, Neuroimaging, and CSF Biomarkers using Machine Learning.

bioRxiv : the preprint server for biology·2026
Same author

An <i>APOE</i> *4-Informed Genomic Atlas of the X Chromosome in Alzheimer's Disease.

medRxiv : the preprint server for health sciences·2026
Same author

Effects of α-synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Plasma proteomic signatures of preclinical Alzheimer's disease in clinically unimpaired older adults.

Molecular neurodegeneration·2026
Same author

Plasma phosphorylated tau 217 detects amyloid-β in neuronal synuclein disease.

NPJ Parkinson's disease·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 14, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.2K

生物标志物 生物标志物

Julie E Oomens1, Theresa M Harrison2, Jeffrey L Dage3,4,5

  • 1Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|January 12, 2026
PubMed
概括
此摘要是机器生成的。

将血pTau217数据与神经成像和人口统计信息相结合,可以增强阿尔茨海默病的研究. 这一组合的数据集有助于了解不同人群的疾病进展和病理学.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

744

相关实验视频

Last Updated: Jan 14, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.2K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

744

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物研究 生物标志物研究
  • 数据整合数据集成

背景情况:

  • 数据的可访问性和互操作性对于推进阿尔茨海默病 (AD) 研究至关重要.
  • 整合各种数据集,包括血生物标志物和神经成像,使得新的假设测试成为可能.
  • 来自国家阿尔茨海默氏症和相关痴呆症集中存储库 (NCRAD) 和阿尔茨海默氏症研究中心 (ADRCs) 的公开数据提供了宝贵的资源.

研究的目的:

  • 将来自NCRAD的血pTau217数据与ADRC的神经成像 (SCAN倡议) 和人口统计数据 (国家阿尔茨海默氏症协调中心统一数据集 - NACC UDS) 集成.
  • 提供样本描述,并介绍初始数据探索的结果.
  • 为了解在阿尔茨海默病和相关痴呆症 (ADRD) 中的血生物标志物和神经成像之间的关系奠定基础.

主要方法:

  • 通过NACC和NCRAD程序获得数据访问.
  • 专注于具有可用的Quanterix Simoa HD-X Alzpath血pTau217数据的参与者.
  • 用SCAN倡议的百叶状物值 (>=20) 定义了粉样性病理.
  • 数据集成使用NACC标识符和访问年龄.
  • 斯皮尔曼相关性评估了血pTau217和百叶状物值之间的关联.
  • 接收器操作特征 (ROC) 分析评估了粉样蛋白分类性能.

主要成果:

  • 927名参与者的血pTau217数据可用.
  • 在具有可用的粉样蛋白PET数据 (n=170) 的参与者中,血pTau217与百叶状蛋白值显示出强烈的相关性 (斯皮尔曼的rho=0.59).
  • 昆特里克斯pTau217在分类粉样蛋白状态方面表现出很高的准确性 (ROC AUC = 0.92,准确率 = 85%).
  • 对于参与者的子集,Tau PET数据也可用.

结论:

  • 对SCAN PET和NCRAD等离子体数据的整合为ADRD研究创造了宝贵的资源.
  • 综合数据集已经显示出显著的人口多样性 (36%).
  • 预计SCAN倡议和ADRC通过成像研究ADRD研究清晰度联盟 (CLARiTI) 的持续努力将增加样本大小并进一步增强资源.